Hypertension

Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension
The development of angiotensin II receptor blockers (ARB) as a new class of drugs for the management of hypertension has elicited the attention of many clinicians worldwide with the aim of improving blood pressure (BP) control as well as cardiovascular protection.

Milan, Italy
Italy
Arterial hypertension: second-line treatment. Try other single-agent treatments.
(1) Reliable evidence supports the use of thiazide diuretics (chlortalidone or hydrochlorothiazide) as first-line treatment for uncomplicated arterial hypertension.


USA
A Comparison of the Aldosterone-blocking Agents Eplerenone and Spironolactone
Improved understanding of the adverse pharmacological properties of aldosterone has prompted investigation of the clinical benefits of blocking aldosterone at the receptor level.

Dundee, UK
UK
Beta-blockers in the management of hypertension: focus on nebivolol
Hypertension is a major cardiovascular risk factor but most patients remain asymptomatic for many years.

Washington, DC 20422
USA
The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabeti
Background: Placebo-controlled trials have found that angiotensin-converting enzyme inhibitors (ACEIs) decrease proteinuria and slow the progression of nondiabetic nephropathies.

Nice, France
France
Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results
OBJECTIVE: Angiotensin-converting enzyme (ACE) inhibitors have been shown to lower central augmentation index (cAI), an index of arterial wave reflection, more than beta-blockers.


Germany
Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and ef
Pharmacological treatment of hypertension is effective in preventing cardiovascular and renal complications.

Lausanne, Switzerland
Switzerland
The effect of tai chi exercise on blood pressure: a systematic review
A systematic review of the literature on the effect of tai chi exercise on blood pressure (BP) was performed.

Boston, MA
USA
Efficacy and Safety of Fixed Combinations of Irbesartan/Hydrochlorothiazide in Older vs Younger Pati
Subgroup analysis of the Irbesartan/Hydrochlorothiazide Blood Pressure Reductions in Diverse Patient Populations (INCLUSIVE) trial evaluated the efficacy and safety of irbesartan/hydrochlorothiazide (HCTZ) fixed combinations in patients aged 65 years or older with uncontrolled systolic blood pressure (SBP) after >/=4 weeks of antihypertensive monotherapy.


USA
Treatment with metoprolol succinate, a selective Beta adrenergic blocker, lowers blood pressure with
Insulin resistance is a risk factor for cardiovascular disease. Therapies to lower blood pressure should not decrease insulin sensitivity, especially among high-risk patients such as diabetics.

Philadelphia, PA
USA